A carregar...
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatment
The BRAF inhibitor vemurafenib is currently used for treating patients with BRAF V600E mutant melanoma. However, the responses to vemurafenib are generally partial and of relatively short duration. Recent evidence suggests that activation of the epidermal growth factor receptor (EGFR)/erbB signaling...
Na minha lista:
| Publicado no: | Melanoma Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394744/ https://ncbi.nlm.nih.gov/pubmed/24709886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000060 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|